RBC Capital Sticks to Their Hold Rating for Gilead Sciences (GILD)
In a report released today, Brian Abrahams from RBC Capital maintained a Hold rating on Gilead Sciences (GILD – Research Report), with a price ...
Los Angeles Business Journal3d
Arrowhead Pharma Shares See Big Price Jump
The share price in Arrowhead Pharmaceuticals Inc. jumped by more than 48% in the two months since it hit its lowest value of the past year. On Oct. 10, ...
Why Is Sarepta Therapeutics (SRPT) Up 4.9% Since Last Earnings Report?
Sarepta Therapeutics (SRPT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Edgewise falls after FDA posts Warning Letter to trial investigator
Shares of Edgewise Therapeutics (EWTX) are moving lower after the FDA posted Warning Letter sent to Han Phan, a principal investigator for ...